Stocks TelegraphStocks Telegraph
Stock Ideas

MDCX Stock Analyst Ratings, Estimated Earnings and Price Targets

NASDAQ : MDCX

Medicus Pharma Common Stock

$1.68
-0.015-0.89%
Open: 12:59 PM
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

MDCX Stock 12 Month Analyst Forecast

According to evaluations from 13 analysts over the past year, the consensus analyst rating for MDCX stock is "Buy". The average price target based on the past year stands at $27.00, with estimates ranging from $27.00 to $27.00.

Eps Overview

Growth Next 5yrs
4.02%
Last Quarter
- $0.65
Past Year
- $2.11
Growth Past 5yrs
N/A
Next Quarter
- $0.23
Estimate Next Year
-

Consensus Rating

Loading...

Consensus Price Target

Highest Price Target

$27.00

NaN% Upside

Mean Price Target

$27.00

NaN% Upside

Lowest Price Target

$27.00

NaN% Upside

Recent Analyst Ratings

Upgrades, Downgrades, New Coverage

Actual EPS vs Estimated EPS

MDCX Earnings Per Share (EPS) History

According to financial reports, MDCX (NYSE: MDCX) reported an actual EPS of $-0.65 for the quarter ending on Nov 14, 2025, compared to an estimated $-0.38, resulting in a 71.05% surprise. In the prior quarter (Aug 11, 2025), MDCX recorded an actual EPS of $-0.43 with a 10.26% surprise. See MDCX's full earnings history.

Earnings History

EPS Surprise Factor Analysis

MDCX has experienced notable EPS surprises, with the latest quarter ending Nov 14, 2025 showing a 71.05% beat. Previously, the quarter ending Aug 11, 2025 recorded a 10.26% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.

Report DateActualForecastSurprise Factor
Nov 14, 2025-0.65-0.38+71.05%
Aug 11, 2025-0.43-0.39+10.26%
May 12, 2025-0.42-0.23+82.61%
Mar 28, 2025-0.18-0.32-43.75%
Nov 22, 2024-0.22911-0.229110
Aug 22, 2024-0.34-0.15+126.67%

After EPS Prices

MDCX stock frequently reacts to earnings reports. Following the Nov 14, 2025 earnings, the share price saw a 2.73% rise before closing. On the 7th day after the report, MDCX shares recorded a -10.00% decline. Analyze historical MDCX stock performance post-earnings.

Earning DateBefore EPS ChangeNext Day Closing Price7th Day Closing Price
Nov 14, 2025$2.26+2.73%$2.30+4.55%$1.98-10.00%
Aug 11, 2025--$2.24+13.71%$2.04+3.55%
May 12, 2025--$5.50+13.17%$7.71+58.64%
Mar 28, 2025$3.30+5.43%$3.72+18.85%$3.63+15.97%
Nov 22, 2024$2.20+14.58%$2.07+7.81%$2.80+45.83%
Aug 22, 2024------

Frequently Asked Questions

Is MDCX stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given MDCX stock an average recommendation of Buy. 13 analysts have given their ratings to MDCX out of which 0 analysts have given strong buy call, 13 analysts have given buy call, 0 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $27.00 gives the stock implied upside of roughly 1,526.51% over the next year or so.
What have analysts suggested for MDCX highest price target?
Analysts suggest MDCX's stock price would rise to a high of $27.00.
What is the lowest price target analysts expect for MDCX over the next year?
Within the next 12 months, analysts predict the MDCX stock price could move to $27.00.
What is the average target price for MDCX?
MDCX stock has an average analyst estimate of $27.00.
At its current price, how far is MDCX from its average target price?
MDCX shares are currently trading 1,526.51% above this price target.
What were MDCX’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.65 versus consensus estimates of - $0.38, and below the comparable year-ago quarter’s EPS of - $0.23.
What are the current estimates for quarterly and annual earnings per share?
MDCX's forecasts by analysts estimating quarterly EPS at - $0.23 and - for the whole year.
What has MDCX's growth been in the past five years and what is expected in the next five years?
The analysts have projected 4.02% EPS growth for MDCX in the next five years, compared to growth rates of N/A in the past five years.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings CalendarStocks Watchlist
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph